Camp4 Therapeutics Corp
CAMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001736730
In the last 90 days, Camp4 Therapeutics Corp insiders filed 5 open-market purchases and 4 sales; 61 institutions reported holding it in 13F filings for Q2 2026, worth $182.2M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Camp4 Therapeutics Corp as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +11 vs. Q3 2025
- Shares held
- 38.2M
- +10.0M (+35.6%) vs. Q3 2025
- Total value
- $234.6M
- +$150.0M (+177.2%) vs. Q3 2025
- New holders
- 13
- 11 more added
- Sold out
- 2
- 10 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CAMP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $182.2M |
| Q1 2026 | 46 | $175.5M |
| Q4 2025 | 40 | $234.6M |
| Q3 2025 | 29 | $84.6M |
| Q2 2025 | 29 | $17.0M |
| Q1 2025 | 39 | $50.7M |
| Q4 2024 | 36 | $67.1M |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Camp4 Therapeutics Corp; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 18 | $0 | 0.00% | −935−98.1% | Reduced |
| SBI Securities Co., Ltd. | 10 | $61 | 0.00% | −5−33.3% | Reduced |
| Bank of America Corp | 22 | $135 | 0.00% | −261−92.2% | Reduced |
| BNP Paribas Arbitrage, SA | 33 | $202 | 0.00% | −45−57.7% | Reduced |
| Tower Research Capital LLC (TRC) | 406 | $2.49K | 0.00% | −5,243−92.8% | Reduced |
| UBS Group AG | 5,145 | $31.5K | 0.00% | −1,898−26.9% | Reduced |
| Morgan Stanley | 9,914 | $60.8K | 0.00% | +9,911+330,366.7% | Added |
| China Universal Asset Management Co., Ltd. | 10,000 | $61.3K | 0.00% | +10,000 | New |
| Millennium Management LLC | 10,102 | $61.9K | 0.00% | −84,969−89.4% | Reduced |
| Jefferies Financial Group Inc. | 11,361 | $69.6K | 0.00% | +11,361 | New |
| Mariner, LLC | 15,371 | $94.2K | 0.00% | −1,927−11.1% | Reduced |
| Bank of New York Mellon Corp | 18,718 | $114.7K | 0.00% | +18,718 | New |
| Omers Administration Corp | 18,800 | $115.2K | 0.00% | +18,800 | New |
| Goldman Sachs Group Inc | 18,823 | $115.4K | 0.00% | +18,823 | New |
| Citigroup Inc | 21,403 | $131.2K | 0.00% | +21,403 | New |
| Bridgeway Capital Management, LLC | 25,000 | $153.3K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 25,534 | $156.5K | 0.00% | +25,534 | New |
| ExodusPoint Capital Management, LP | 34,720 | $212.8K | 0.00% | +34,720 | New |
| State Street Corp | 39,700 | $243.4K | 0.00% | +13,700+52.7% | Added |
| Barclays PLC | 73,601 | $451.2K | 0.00% | +73,531+105,044.3% | Added |
| Northern Trust Corp | 74,509 | $456.7K | 0.00% | +59,894+409.8% | Added |
| Victory Capital Management Inc | 82,790 | $507.5K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 94,531 | $579.5K | 0.00% | −2,840−2.9% | Reduced |
| 683 Capital Management, LLC | 126,363 | $774.6K | 0.06% | +126,363 | New |
| Alyeska Investment Group, L.P. | 200,000 | $1.23M | 0.00% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 228,894 | $1.40M | 1.11% | +228,894 | New |
| EcoR1 Capital, LLC | 325,000 | $1.99M | 0.09% | +325,000 | New |
| Geode Capital Management, LLC | 336,293 | $2.06M | 0.00% | +275,922+457.0% | Added |
| BlackRock, Inc. | 390,160 | $2.39M | 0.00% | +378,723+3,311.4% | Added |
| HarbourVest Partners LLC | 1,271,948 | $7.80M | 4.48% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,672,960 | $10.3M | 0.00% | +1,359,454+433.6% | Added |
| Trails Edge Capital Partners, LP | 1,983,986 | $12.2M | 3.00% | +1,983,986 | New |
| AH Capital Management, L.L.C. | 2,125,339 | $13.0M | 0.82% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 2,181,679 | $13.4M | 0.02% | +220,895+11.3% | Added |
| Balyasny Asset Management LLC | 2,436,900 | $14.9M | 0.03% | +2,436,900 | New |
| Enavate Sciences GP, LLC | 3,035,825 | $18.6M | 3.67% | −749,977−19.8% | Reduced |
| Vivo Capital, LLC | 4,246,568 | $26.0M | 1.68% | +325,000+8.3% | Added |
| FMR LLC | 4,918,243 | $30.1M | 0.00% | +1,894,809+62.7% | Added |
| 5AM Venture Management, LLC | 5,869,091 | $36.0M | 11.31% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 6,307,636 | $38.8M | 0.02% | +1,666,666+35.9% | Added |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −653,594−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |